1-877-936-8422

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

Prostate

This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with enzalutamide.
Prostate
III
Moses, Kelvin
NCT03395197
VICCURO17115
Learn More

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here:

Self-Referral Form
NCI Designated Cancer Center
NCCN National Comprehensive Cancer Network
NCI National Clinical Trials Network
CEO Cancer Gold Standard